Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Probable Alzheimer's Disease”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Not applicableStudy completedNCT05364307
What this trial is testing

Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentMemory Loss+2 more
Global Alzheimer's Platform Foundation 1,555
Not applicableWithdrawnNCT04041895
What this trial is testing

Detecting Probable Alzheimer's Disease From Speech Using Linguistical Analysis

Who this might be right for
Alzheimer DiseaseDementia
East Tennessee State University
Testing effectiveness (Phase 2)Study completedNCT03856359
What this trial is testing

Trial of Rifaximin in Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Duke University 10
Testing effectiveness (Phase 2)Study completedNCT05307692
What this trial is testing

Seltorexant in Participants With Probable Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Research & Development, LLC 88
Testing effectiveness (Phase 2)Study completedNCT00051909
What this trial is testing

Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 200
Testing effectiveness (Phase 2)Study completedNCT03069014
What this trial is testing

Study of LM11A-31-BHS in Mild-moderate AD Patients

Who this might be right for
Mild to Moderate Alzheimer's Disease
PharmatrophiX Inc. 242
Post-approval studies (Phase 4)Study completedNCT00561392
What this trial is testing

Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 208
Post-approval studies (Phase 4)Study completedNCT00731224
What this trial is testing

Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 380
Post-approval studies (Phase 4)Study completedNCT00622713
What this trial is testing

A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)

Who this might be right for
Alzheimer's Disease
Novartis 228
Early research (Phase 1)Study completedNCT01009359
What this trial is testing

Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Bayer 22
Early research (Phase 1)Study completedNCT03545789
What this trial is testing

Phase 1 Test-retest Evaluation of [18F]MNI-958 PET

Who this might be right for
Healthy VolunteersAlzheimer DiseaseProgressive Supranuclear Palsy
Invicro 16
Not applicableStudy completedNCT03622905
What this trial is testing

ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Functional Neuromodulation Ltd 74
Large-scale testing (Phase 3)Study completedNCT00261573
What this trial is testing

The Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia

Who this might be right for
Alzheimer DiseaseVascular Dementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 593
Large-scale testing (Phase 3)Study completedNCT00219232
What this trial is testing

An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 868
Large-scale testing (Phase 3)Study completedNCT00236574
What this trial is testing

Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Who this might be right for
DementiaAlzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 974
Testing effectiveness (Phase 2)Study completedNCT01073228
What this trial is testing

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseCentral Nervous System DiseasesCognition
FORUM Pharmaceuticals Inc 409
Early research (Phase 1)Study completedNCT01153607
What this trial is testing

Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Lantheus Biosciences Ltd. 24
Not applicableEnded earlyNCT02263235
What this trial is testing

In Vivo Alzheimer Proteomics

Who this might be right for
Probable Alzheimer DiseaseParkinson DiseaseNeurological Disease Without Cognitive Degradation+2 more
University Hospital, Montpellier 89
Testing effectiveness (Phase 2)Study completedNCT01436045
What this trial is testing

Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.

Who this might be right for
Alzheimer's Disease
HealthPartners Institute 12
Large-scale testing (Phase 3)Study completedNCT00428389
What this trial is testing

Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 262
Load More Results